Auris Medical Closes Two US Patent Acquisitions Related to the Use of Betahistine for the Treatment of Depression and ADHD Pharmaceutical Investing
MediPharm Labs Signs Committed Term Sheet for $20 Million Debt Facility With Schedule 1 Bank Cannabis Investing News
Lexaria’s DehydraTECHTM Formulation Delivers 475% More CBD to Bloodstream after 15 Minutes than Conventional Industry Formulations Cannabis Investing News
Cronos Group and MediPharm Labs Enter $30 Million Multi-Year Private Label Cannabis Concentrate Supply Agreement with Potential to Increase to $60 Million Cannabis Investing News
ARCA biopharma Submits Patent Application to US Patent and Trademark Office for Atrial Fibrillation Pharmaceutical Investing
BriaCell Approves New Board of Directors and Chairman at Annual and Special Meeting of Shareholders Biotech Investing
